CD34+ Hematopoietic Stem Cell Count Is Predictive of Vascular Event Occurrence in Children with Sickle Cell Disease.

Manoëlle KossorotoffMariane De MontalembertValentine BrousseDominique LasneEmmanuel CurisDavid M SmadjaRomaric LacroixSebastien BertilElodie MassonIsabelle DesguerreDamien BonnetPascale Gaussem

Published in: Stem cell reviews and reports (2019)

CD34+ cell count at steady state is a promising biomarker of further vascular event in children with SCD.

Keyphrases

hematopoietic stem cell
young adults
risk assessment
single cell
peripheral blood
cell therapy
stem cells
nk cells